Table 3.
Bivariate analysis of postoperative complications of 56 patients with Hartmann’s reversal
| Variables | No complications (N = 47) | Postoperative complications (N=9) | p-value |
|---|---|---|---|
| Male gender (N=37) | 29 (61.7%) | 8 (88.9%) | 0.113 |
| Age (years) | 56.8+14.7 | 58.5+20 | 0.510 |
| Medical comorbidities (N=23) | 18 (38.3%) | 5 (55.6%) | 0.274 |
| Multiple comorbidities (N=7) | 4 (8.5%) | 3 (33.3%) | 0.039* |
| Hartmann - conversion interval (months) | 8.5+6.3 | 11.8+10 | 0.277 |
| Hartmann’s indication | 0.900 | ||
| Cancer (N=25) | 21 (44.7%) | 4 (44.4%) | |
| Diverticulitis (N=10) | 8 (17%) | 2 (22.2%) | |
| Anastomotic leakage (N=4) | 3 (6.4%) | 1 (11.1%) | |
| Other indications (17) | 15 (31.9%) | 2 (22.2%) | |
| Cancer location – sigmoid (N=13) | 11 (52.4%) | 2 (50%) | 0.996 |
| Manual surgical technique (N=44) | 37 (78.7) | 7 (77.8%) | 0.949 |
| Type of anastomosis | 0.474 | ||
| End to end (N=32) | 27 (60%) | 5 (55.6%) | |
| End to side (N=15) | 11 (24.4%) | 4 (44.4%) | |
| Hemoglobin (g/ dL) | 13.7±1.4 | 14.1±1.7 | 0.369 |
| Total proteins (g/ dL) | 7.4±0.5 | 7.3±0.3 | 0.755 |
| *p<0.05 |